A new study carried out by the University of Tel Aviv (Israel) has discovered a new medical application of the non-psychoactive component of the plant: the healing of bone fractures. The research, carried out in mice, found that the administration of the cannabinoid cannabidiol (CBD), which represents around 40% of its extracts, isolated from tetrahydrocannabinol (THC), its major psychoactive component, could significantly improve the healing process of the femur after only eight weeks.
Scientists discovered that cannabinoid receptors act within our bodies by stimulating bone formation and inhibited bone loss . In fact, it not only makes the bones stronger during healing, but improves the maturation of the collagen matrix, providing the basis for the new mineralization of bone tissue. “After being treated with CBD, the healed bone will be more difficult to break in the future,” said Yankel Gabet, professor at the Bone Research Laboratory in the Department of Anatomy and Anthropology at UTA’s Sackler School of Medicine. and study leader.
This, in his opinion, paves the way for a promising future in the use of cannabinoid drugs to combat osteoporosis and other bone-related diseases. “The clinical potential of cannabinoid- related compounds is undeniable at this time,” he said. “Although there is still a lot of work to be done in the development of appropriate therapies, the main agent in our study, CBD, is an effective anti-inflammatory that lacks psychoactivity, ” he added.
As Gabet explained, “ our body is equipped with a cannabinoid system, which regulates vital and non-vital systems. We respond to cannabis because we are made of receptors that can be activated by compounds in the cannabis plant. “
